Millennium Management »

Crispr Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 17k 62.60
2023-09-30 $6.2M 136k 45.39
2023-06-30 $6.3M 113k 56.14
2023-03-31 $12M 260k 45.23
2022-12-31 $494k 12k 40.68
2022-06-30 $1.2M 20k 60.75
2022-03-31 $4.2M 67k 62.76
2021-09-30 $25M 222k 111.93
2021-06-30 $19M 120k 161.89
2021-03-31 $16M 133k 121.87
2020-12-31 $9.5M 62k 153.10
2020-06-30 $3.3M 46k 73.48
2019-12-31 $19M 312k 60.91
2019-09-30 $4.4M 107k 40.98
2018-09-30 $3.0M 67k 44.34
2017-12-31 $2.2M 95k 23.48
2017-09-30 $1.3M 75k 17.87
2017-06-30 $529k 33k 16.03
2016-12-31 $241k 12k 20.23